Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
Linong Ji,Ying Du,Min Xu,Xiangjun Zhou,Zhaohui Mo,Jianhua Ma,Jiarui Li,Yufeng Li,Jingna Lin,Yanjun Wang,Jing Yang,Weihong Song,Hui Jin,Shuguang Pang,Hui Liu,Ping Li,Jie Liu,Minxiu Yao,Wenhui Li,Xiaohong Jiang,Feixia Shen,Houfa Geng,Haifeng Zhou,Jianmin Ran,Minxiang Lei,Yinghong Du,Shandong Ye,Qingbo Guan,Wenshan Lv,Huiwen Tan,Tao Chen,Jinkui Yang,Guijun Qin,Shiyun Li,Lei Chen
DOI: https://doi.org/10.1007/s00125-021-05460-0
IF: 8.2
2021-05-26
Diabetologia
Abstract:A Correction to this paper has been published: 10.1007/s00125-021-05460-0
endocrinology & metabolism